HK67087A - Pyridine derivatives as anti-inflammatory and immunoregulatory agents - Google Patents
Pyridine derivatives as anti-inflammatory and immunoregulatory agentsInfo
- Publication number
- HK67087A HK67087A HK670/87A HK67087A HK67087A HK 67087 A HK67087 A HK 67087A HK 670/87 A HK670/87 A HK 670/87A HK 67087 A HK67087 A HK 67087A HK 67087 A HK67087 A HK 67087A
- Authority
- HK
- Hong Kong
- Prior art keywords
- inflammatory
- pyridine derivatives
- immunoregulatory agents
- immunoregulatory
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/276,242 US4371696A (en) | 1980-07-14 | 1981-06-26 | Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK67087A true HK67087A (en) | 1987-09-25 |
Family
ID=23055809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK670/87A HK67087A (en) | 1981-06-26 | 1987-09-17 | Pyridine derivatives as anti-inflammatory and immunoregulatory agents |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4371696A (fr) |
| JP (1) | JPS58916A (fr) |
| AU (1) | AU528433B2 (fr) |
| BE (1) | BE890374R (fr) |
| CH (1) | CH648483A5 (fr) |
| DE (1) | DE3215648A1 (fr) |
| FR (1) | FR2508904B2 (fr) |
| GB (1) | GB2100600B (fr) |
| GR (1) | GR75753B (fr) |
| HK (1) | HK67087A (fr) |
| IE (1) | IE51727B1 (fr) |
| IL (1) | IL63699A0 (fr) |
| IT (1) | IT1200569B (fr) |
| KE (1) | KE3458A (fr) |
| LU (1) | LU83827A1 (fr) |
| MY (1) | MY8500351A (fr) |
| NL (1) | NL8105744A (fr) |
| NZ (1) | NZ198215A (fr) |
| PH (1) | PH17742A (fr) |
| SE (1) | SE442110B (fr) |
| SG (1) | SG56084G (fr) |
| ZA (1) | ZA821139B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6179685U (fr) * | 1984-10-26 | 1986-05-27 | ||
| JPS61207304A (ja) * | 1985-03-11 | 1986-09-13 | Toyo Soda Mfg Co Ltd | 農園芸用殺菌剤 |
| JPH0445817Y2 (fr) * | 1988-09-09 | 1992-10-28 | ||
| US5610198A (en) * | 1994-03-18 | 1997-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3558640A (en) * | 1967-12-20 | 1971-01-26 | Merck & Co Inc | Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives |
| GB1434271A (en) * | 1972-09-28 | 1976-05-05 | Squibb & Sons Inc | Cephalosporins |
| US4246263A (en) * | 1979-10-15 | 1981-01-20 | Pfizer Inc. | Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions |
-
1981
- 1981-06-26 US US06/276,242 patent/US4371696A/en not_active Expired - Fee Related
- 1981-08-31 GR GR65912A patent/GR75753B/el unknown
- 1981-08-31 IL IL63699A patent/IL63699A0/xx not_active IP Right Cessation
- 1981-08-31 NZ NZ198215A patent/NZ198215A/en unknown
- 1981-09-16 BE BE0/205976A patent/BE890374R/fr not_active IP Right Cessation
- 1981-11-06 GB GB08133616A patent/GB2100600B/en not_active Expired
- 1981-11-17 AU AU77553/81A patent/AU528433B2/en not_active Ceased
- 1981-11-24 IE IE2748/81A patent/IE51727B1/en unknown
- 1981-11-26 FR FR8122143A patent/FR2508904B2/fr not_active Expired
- 1981-11-27 SE SE8107101A patent/SE442110B/sv not_active IP Right Cessation
- 1981-12-01 CH CH7697/81A patent/CH648483A5/fr not_active IP Right Cessation
- 1981-12-10 LU LU83827A patent/LU83827A1/fr unknown
- 1981-12-21 NL NL8105744A patent/NL8105744A/nl not_active Application Discontinuation
-
1982
- 1982-01-11 PH PH26722A patent/PH17742A/en unknown
- 1982-01-18 IT IT19162/82A patent/IT1200569B/it active
- 1982-02-05 JP JP57017374A patent/JPS58916A/ja active Pending
- 1982-02-22 ZA ZA821139A patent/ZA821139B/xx unknown
- 1982-04-27 DE DE19823215648 patent/DE3215648A1/de not_active Ceased
-
1984
- 1984-08-13 SG SG560/84A patent/SG56084G/en unknown
- 1984-09-24 KE KE3458A patent/KE3458A/xx unknown
-
1985
- 1985-12-30 MY MY351/85A patent/MY8500351A/xx unknown
-
1987
- 1987-09-17 HK HK670/87A patent/HK67087A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ198215A (en) | 1984-07-06 |
| DE3215648A1 (de) | 1983-01-13 |
| ZA821139B (en) | 1983-01-26 |
| US4371696A (en) | 1983-02-01 |
| GB2100600B (en) | 1983-09-14 |
| AU528433B2 (en) | 1983-04-28 |
| JPS58916A (ja) | 1983-01-06 |
| IT8219162A0 (it) | 1982-01-18 |
| KE3458A (en) | 1984-10-12 |
| IE51727B1 (en) | 1987-03-04 |
| SG56084G (en) | 1985-03-08 |
| FR2508904A2 (fr) | 1983-01-07 |
| FR2508904B2 (fr) | 1985-11-29 |
| IT1200569B (it) | 1989-01-27 |
| CH648483A5 (fr) | 1985-03-29 |
| IL63699A0 (en) | 1981-11-30 |
| BE890374R (fr) | 1982-03-16 |
| SE442110B (sv) | 1985-12-02 |
| IE812748L (en) | 1982-12-26 |
| GR75753B (fr) | 1984-08-02 |
| NL8105744A (nl) | 1983-01-17 |
| GB2100600A (en) | 1983-01-06 |
| LU83827A1 (fr) | 1982-05-07 |
| MY8500351A (en) | 1985-12-31 |
| PH17742A (en) | 1984-11-27 |
| SE8107101L (sv) | 1982-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0194153A3 (en) | Pyridine derivatives | |
| DE3377574D1 (en) | Hydroxybenzylamino derivatives as anti-inflammatory agents | |
| GB2173788B (en) | Pyridine derivatives | |
| EP0003383A3 (en) | 4-amino-3-sulfonamido pyridine derivatives and their use | |
| GB8514278D0 (en) | Pyridine derivatives | |
| GB8616238D0 (en) | Pyridine derivatives | |
| GB2100600B (en) | Pyridine derivatives as anti-inflammatory and immunoregulatory agents | |
| GB8509276D0 (en) | Pyridine derivatives | |
| AR242212A1 (es) | Un proceso para la preparacion de nuevos derivados de 1,3-dihidro-6-¡1- ciano-1-isopropil-n-fenetil-n-metil-omega-aminoalquil-7-hidro xi-furo-(3,4c)-piridina | |
| AU7755381A (en) | Anti-inflammatory immunoregulatory pyridine derivatives | |
| GB8422461D0 (en) | Pyridine derivatives | |
| GB8426738D0 (en) | Pyridine derivatives | |
| PT82007B (en) | Pyridine derivatives | |
| ZA822008B (en) | New pyridine derivatives | |
| GB8507008D0 (en) | Pyridine derivatives | |
| GB8520007D0 (en) | Pyridine derivatives | |
| GB8520169D0 (en) | Pyridine derivatives | |
| GB8521304D0 (en) | Pyridine derivatives | |
| GB2167064B (en) | Pyridine derivatives | |
| ZA821968B (en) | Pyridine derivatives | |
| EP0194746A3 (en) | Pyridine derivatives | |
| GB8405999D0 (en) | Pyridine derivatives | |
| GB8417517D0 (en) | Pyridine derivatives | |
| GB8417518D0 (en) | Pyridine derivatives | |
| GB8413690D0 (en) | Pyridine derivatives |